Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
991 hedge funds and large institutions have $39B invested in Allergan plc in 2019 Q1 according to their latest regulatory filings, with 118 funds opening new positions, 382 increasing their positions, 359 reducing their positions, and 119 closing their positions.
9% more capital invested
Capital invested by funds: $35.8B → $39B (+$3.23B)
6% more repeat investments, than reductions
Existing positions increased: 382 | Existing positions reduced: 359
1% less first-time investments, than exits
New positions opened: 118 | Existing positions closed: 119
2% less funds holding
Funds holding: 1,007 → 991 (-16)
11% less call options, than puts
Call options by funds: $655M | Put options by funds: $733M
18% less funds holding in top 10
Funds holding in top 10: 33 → 27 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Veritas Asset Management
London,
United Kingdom
|
+$373M |
| 2 |
AL
Appaloosa LP
Short Hills,
New Jersey
|
+$288M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$259M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$184M |
| 5 |
SHCM
Sachem Head Capital Management
New York
|
+$112M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Edgewood Management
Greenwich,
Connecticut
|
-$864M |
| 2 |
Goldman Sachs
New York
|
-$153M |
| 3 |
EIP
Epoch Investment Partners
New York
|
-$146M |
| 4 |
O
OrbiMed
New York
|
-$128M |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$110M |
AGN Hedge Fund Activity: Q1 2019 in Review
991 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q1 2019, worth a combined $39B — up 9% from $35.8B a quarter earlier.
Sellers outnumbered buyers: 119 funds closed out of AGN and 118 opened new positions — a net loss of 1 holder — while 359 trimmed existing stakes and 382 added.
The largest buyer was Veritas Asset Management, opening a new position worth an estimated $373M. The largest seller was Edgewood Management, cutting an estimated $864M.
- 991 institutional investors held Allergan plc (AGN) as of Q1 2019, down from 1,007 in Q4 2018.
- Funds reported $39B of Allergan plc stock for Q1 2019, up 9% quarter-over-quarter.
- 118 funds opened new Allergan plc positions in Q1 2019 and 119 closed out, a net change of -1 holder.
- The largest Allergan plc buyer in Q1 2019 was Veritas Asset Management, an estimated $373M added.
- The largest Allergan plc seller in Q1 2019 was Edgewood Management, an estimated $864M sold.
Based on aggregated 13F filings for Q1 2019.